SG Americas Securities
ONCT

SG Americas Securities’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History

SG Americas Securities’s Portfolio ONCT Stock Details ONCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-595
Closed -$27K – 3578
2021
Q4 		$27K Sell
595
-736
-55% -$49.5K ﹤0.01% 3248
2021
Q3 		$111K Buy
1,331
+568
+74% +$47K ﹤0.01% 3617
2021
Q2 		$73K Buy
+763
New +$90.5K ﹤0.01% 2717
2019
Q2 		– Sell
-245
Closed -$41K – 3512
2019
Q1 		$41K Buy
+245
New +$36.5K ﹤0.01% 3226

Other funds holding ONCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
QPW
Quantum Private Wealth Tampa, Florida $324M AUM 37.9% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SG Americas Securities's ONCT Position: Q1 2022 in Review

SG Americas Securities sold out of Oncternal Therapeutics, Inc. Common Stock (ONCT) in Q1 2022, closing a stake of 595 shares — an estimated $27K sold.

SG Americas Securities first reported a position in ONCT in Q1 2019 and held it in 4 quarters. The position peaked at $111K in Q3 2021. 78 funds tracked by Wall St. Rank hold ONCT as of Q1 2022.

  • SG Americas Securities reported no remaining Oncternal Therapeutics, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • SG Americas Securities sold 595 Oncternal Therapeutics, Inc. Common Stock shares in Q1 2022, an estimated $27K.
  • SG Americas Securities first reported a position in Oncternal Therapeutics, Inc. Common Stock in Q1 2019 and held it in 4 quarters.
  • SG Americas Securities's Oncternal Therapeutics, Inc. Common Stock position peaked at $111K in Q3 2021.
  • 78 funds tracked by Wall St. Rank held Oncternal Therapeutics, Inc. Common Stock as of Q1 2022.

Based on SG Americas Securities's 13F filing for Q1 2022, filed 29 Apr 2022.